Selective proteolysis of human type 2 deiodinase: A novel ubiquitin-proteasomal mediated mechanism for regulation of hormone activation

被引:135
作者
Gereben, B [1 ]
Goncalves, C [1 ]
Harney, JW [1 ]
Larsen, PR [1 ]
Bianco, AC [1 ]
机构
[1] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Thyroid Div, Boston, MA 02115 USA
关键词
D O I
10.1210/me.14.11.1697
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We investigated the mechanism by which T-4 regulates its activation to T-3 by the type 2 iodothyronine deiodinase (D2). D2 is a short- lived (t(1/2) 50 min), 31-kDa endoplasmic reticulum (ER) integral membrane selenoenzyme that generates intracellular T-3. inhibition of the ubiquitin (Ub) activating enzyme, E1, or MG132, a proteasome blocker, inhibits both the basal and substrate-induced acceleration of D2 degradation. Using a catalytically active transiently expressed FLAG-tagged-NH2-D2, we found rapid synthesis of high molecular mass (100-300 kDa) Ub-D2 conjugates that are catalytically inactive. Ub-D2 increases when cells are exposed to D2: substrate or MG132 and disappears rapidly after El inactivation. Fusion of FLAG epitope to the COOH terminus of D2 prolongs its half-life approximately 2.5-fold and increases the levels of active and, especially, Ub-D2. This indicates that COOH-terminal modification interferes with proteasomal uptake of Ub-D2 that can then be deubiquitinated. Interestingly, the type 1 deiodinase, a related selenoenzyme that also converts T-4 to T-3 but with a half-life of >12 h, is inactivated but not ubiquitinated or degraded after exposure to substrate. Thus, ubiquitination of the ER-resident enzyme D2 constitutes a specific posttranslational mechanism for T-4 regulation of its own activation in the central nervous system and pituitary tissues in which D2-catalyzed T-4 to T-3 conversion is the major source of intracellular T-3.
引用
收藏
页码:1697 / 1708
页数:12
相关论文
共 26 条
[1]   SUBSTITUTION OF CYSTEINE FOR SELENOCYSTEINE IN TYPE-I IODOTHYRONINE DEIODINASE REDUCES THE CATALYTIC EFFICIENCY OF THE PROTEIN BUT ENHANCES ITS TRANSLATION [J].
BERRY, MJ ;
MAIA, AL ;
KIEFFER, JD ;
HARNEY, JW ;
LARSEN, PR .
ENDOCRINOLOGY, 1992, 131 (04) :1848-1852
[2]  
BERRY MJ, 1994, ENDOCRINE REV MONOGR, V3, P265
[3]   Ubiquitin and the control of protein fate in the secretory and endocytic pathways [J].
Bonifacino, JS ;
Weissman, AM .
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, 1998, 14 :19-57
[4]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[5]   Regulated intramembrane proteolysis: A control mechanism conserved from bacteria to humans [J].
Brown, MS ;
Ye, J ;
Rawson, RB ;
Goldstein, JL .
CELL, 2000, 100 (04) :391-398
[6]   ACCUMULATION OF P53 IN A MUTANT-CELL LINE DEFECTIVE IN THE UBIQUITIN PATHWAY [J].
CHOWDARY, DR ;
DERMODY, JJ ;
JHA, KK ;
OZER, HL .
MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (03) :1997-2003
[7]   TIGHT CONTROL OF GENE-EXPRESSION IN MAMMALIAN-CELLS BY TETRACYCLINE-RESPONSIVE PROMOTERS [J].
GOSSEN, M ;
BUJARD, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (12) :5547-5551
[8]   Proteins of newly isolated mutants and the amino-terminal proline are essential for ubiquitin-proteasome-catalyzed catabolite degradation of fructose-1,6-bisphosphatase of Saccharomyces cerevisiae [J].
Hämmerle, M ;
Bauer, J ;
Rose, M ;
Szallies, A ;
Thumm, M ;
Düsterhus, S ;
Mecke, D ;
Entian, KD ;
Wolf, DH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (39) :25000-25005
[9]   The ubiquitin system [J].
Hershko, A ;
Ciechanover, A .
ANNUAL REVIEW OF BIOCHEMISTRY, 1998, 67 :425-479
[10]  
LARSEN PR, 1981, ENDOCR REV, V2, P87, DOI 10.1210/edrv-2-1-87